Published Date: 08 Mar 2023
Almost a month has passed with no news of another cancer vaccine breakthrough.
Read Full News1.
Molecular profiling of renal medullary carcinoma identifies TROP2 as a promising therapeutic target
2.
Patients with resected head and neck cancers may benefit clinically from an investigational personalized vaccine.
3.
AI Model Has Promise for Predicting Checkpoint Inhibitor Activity in NSCLC
4.
Underprescribed for Alcohol Use Disorder is pharmacotherapy.
5.
Can the way we talk about cancer change how we interact with the disease?
1.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
2.
The Statistical Horizon of Colorectal Cancer: From Global Trends to Precision Therapies and Colorectal Cancer 2025 Forecasts
3.
Unlocking the Potential of Elotuzumab: A Promising New Cancer Treatment
4.
Cancer Vaccines In India: The Latest Hope In The Fight Against Disease
5.
Omitting Axillary Dissection in Node-Positive Breast Cancer: Insights from the SENOMAC Trial
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part V
4.
The Landscape of First-Line Treatment for Urothelial Carcinoma- Further Discussion
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation